TOP STORIES

• BUSINESS Otsuka Ventures into Antibody Space with Visterra Buyout
  July 12, 2018

• REGULATORY MHLW Selects 9 Priority Prefectures for Generic Promotion Project, but Leaves Tokyo Out
  July 12, 2018

• REGULATORY MHLW Official Expounds on “Authorized Biosimilar” Pricing, 50% Generic Rule Applies for “Biosame” Products
  July 11, 2018

• REGULATORY Tokyo Govt to Launch Support Program for Drug Discovery Startups to Solve Obstacles to Fundraising, IP Strategy
  July 10, 2018

• BUSINESS New Takeda Global Headquarters Designed for LGBT Inclusion
  July 9, 2018

• BUSINESS No Drug Breaks 100 Billion Yen Mark in FY2017 Japan Sales Ranking: Jiho Tally
  July 6, 2018

• BUSINESS Pfizer Wringing Hands over PMP Eligibility for Lorlatinib; It Might Earn 1st Conditional OK, but It’s “4th” ALK Inhibitor
  July 5, 2018

• REGULATORY Several Brand-Name Drug Makers Intend to Withdraw “G1” LLPs
  July 4, 2018

• TRENDS Japan Drug Makers Downsizing Parent Companies; Takeda Sheds Over 1,000 People in Divestitures, R&D Rejig
  July 3, 2018

• REGULATORY MHLW Approves Entyvio, Imfinzi, Lynparza Breast Cancer Use, and More
  July 3, 2018

• BUSINESS Takeda Celebrates Grand Opening for New Global Headquarters
  July 3, 2018

• BUSINESS With Focus on CGRP, Development of New Generation of Preventive Treatments for Migraines Heating Up
  July 2, 2018

• BUSINESS Grilled by Shareholders, Takeda CEO Seeks Understanding for Shire Deal
  June 29, 2018

• BUSINESS Takeda Shareholders Strike Down Dissident Group’s Proposal
  June 28, 2018

• BUSINESS Keytruda’s MSI-H Cancer Indication to Be Reviewed Under Conditional Early Approval System
  June 28, 2018

• BUSINESS Chugai Chairman Prods Drug Makers to Innovate, Chides Calls for Relaxed Pricing
  June 27, 2018

• ACADEMIA Licensee Selection Draws Near for AMED-Backed Cancer Mouth Sores Treatment
  June 26, 2018

• BUSINESS Xofluza Likely to Jolt Japan Flu Market This Winter
  June 25, 2018

• BUSINESS Maviret Sweeping Japan Hep C Market, 80% Share Snatched in Just 4 Months?
  June 22, 2018

• ACADEMIA Nucala, Fasenra to Be Ranked as Strongest Treatments in New Asthma Guidelines: Allergology Society
  June 21, 2018

ページ

• « 先頭
• ‹ Prev
• …
• 138
• 139
• 140
• 141
• 142
• 143
• 144
• 145
• 146
• …
• Next ›
• 最終 »